Market Overview

Oppenheimer Reiterates Outperform Rating, $23 PT for Inter Parfums

Related IPAR
UPDATE: A&F, Hollister Report Signing of Exclusive License Deal with Inter Parfums
Mid-Day Losers From November 18: Omega Protein, Urban Outfitters, Celldex Therapeutics, Amicus Therapeutics, Inter Parfums

In a company update published earlier today, Oppenheimer Holdings reiterated its Outperform rating and $23.00 price target for Inter Parfums, Inc. (NASDAQ: IPAR).

Oppenheimer went on to say “IPAR's very strong 1Q results reflect broad based sales momentum across its portfolio. However, the company chose not to revise guidance, as we await resolution of the Burberry license. Nonetheless, we reiterate our Outperform rating and $23 DCF-derived target price on the shares, as we believe potential downside to IPAR holders from a resolution is limited, while current valuation does not fully reflect the company's robust top line growth and very healthy balance sheet.”

Inter Parfums, Inc. closed yesterday at $16.00

Latest Ratings for IPAR

Nov 2014CitigroupMaintainsBuy
Sep 2014Piper JaffrayInitiates Coverage onNeutral
Aug 2014CitigroupUpgradesNeutralBuy

View More Analyst Ratings for IPAR
View the Latest Analyst Ratings

Posted-In: Oppenheimer HoldingsAnalyst Color Reiteration Analyst Ratings


Related Articles (IPAR)

Around the Web, We're Loving...

Get Benzinga's Newsletters